Skip to content
10-Q

Quarterly Report

AETERNUM HEALTH, INC. AETN

0001493152-24-002413

← back to feed
Filed
Jan 16, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Jan 8, 2024 48.48M sh
Shares Diluted Q3 2024 · Nov 30, 2023 48.48M sh
Shares Diluted Q3 2024 · Nov 30, 2023 48.03M sh
Shares Diluted Q3 2024 · Nov 30, 2022 9.41M sh
Shares Diluted Q3 2024 · Nov 30, 2022 9.03M sh
Operating Cash Flow Q3 2024 · Nov 30, 2023 −$278.4K
Operating Cash Flow restated Q3 2024 · Nov 30, 2022 −$154.27K
Stockholders Equity Q3 2024 · Nov 30, 2023 −$1.18M
Stockholders Equity Q3 2024 · Aug 31, 2023 −$1.08M
Stockholders Equity Q3 2024 · May 31, 2023 −$966.61K
Stockholders Equity Q3 2024 · Feb 28, 2023 −$851.52K
Stockholders Equity restated Q3 2024 · Nov 30, 2022 −$1.21M
Stockholders Equity restated Q3 2024 · Aug 31, 2022 −$1.56M
Stockholders Equity restated Q3 2024 · May 31, 2022 −$1.51M
Stockholders Equity restated Q3 2024 · Feb 28, 2022 −$1.41M
Current Liabilities Q3 2024 · Nov 30, 2023 $469.79K
Current Liabilities Q3 2024 · Feb 28, 2023 $343.48K
Total Liabilities Q3 2024 · Nov 30, 2023 $1.51M
Total Liabilities Q3 2024 · Feb 28, 2023 $1.53M
Current Assets Q3 2024 · Nov 30, 2023 $322.47K
Current Assets Q3 2024 · Feb 28, 2023 $675.27K
Total Assets Q3 2024 · Nov 30, 2023 $323.47K
Total Assets Q3 2024 · Feb 28, 2023 $676.27K
Eps Diluted Q3 2024 · Nov 30, 2023 $0.00
Eps Diluted Q3 2024 · Nov 30, 2023 −$0.01
Eps Diluted restated Q3 2024 · Nov 30, 2022 −$0.01
Eps Diluted restated Q3 2024 · Nov 30, 2022 −$0.02
Eps Basic Q3 2024 · Nov 30, 2023 $0.00
Eps Basic Q3 2024 · Nov 30, 2023 −$0.01
Eps Basic restated Q3 2024 · Nov 30, 2022 −$0.01
Eps Basic restated Q3 2024 · Nov 30, 2022 −$0.02
Sga Expense Q3 2024 · Nov 30, 2023 $35.57K
Sga Expense Q3 2024 · Nov 30, 2023 $99.61K
Sga Expense restated Q3 2024 · Nov 30, 2022 $7.73K
Sga Expense restated Q3 2024 · Nov 30, 2022 $30.52K
Net Income Q3 2024 · Nov 30, 2023 −$103.54K
Net Income Q3 2024 · Nov 30, 2023 −$531K
Net Income Q3 2024 · Aug 31, 2023 −$312.37K
Net Income Q3 2024 · May 31, 2023 −$115.09K
Net Income restated Q3 2024 · Nov 30, 2022 −$59.53K
Net Income restated Q3 2024 · Nov 30, 2022 −$213.81K
Net Income Q3 2024 · Aug 31, 2022 −$52.67K
Net Income Q3 2024 · May 31, 2022 −$101.6K
Operating Income Q3 2024 · Nov 30, 2023 −$99.59K
Operating Income Q3 2024 · Nov 30, 2023 −$480.55K
Operating Income restated Q3 2024 · Nov 30, 2022 −$60.56K
Operating Income restated Q3 2024 · Nov 30, 2022 −$168.77K
Gross Profit Q3 2024 · Nov 30, 2023 −$8.44K
Gross Profit Q3 2024 · Nov 30, 2023 −$15.11K
Gross Profit Q3 2024 · Nov 30, 2022 −$3.39K
Gross Profit Q3 2024 · Nov 30, 2022 −$14.34K
Cost Of Revenue Q3 2024 · Nov 30, 2023 $9.52K
Cost Of Revenue Q3 2024 · Nov 30, 2023 $27.9K
Cost Of Revenue Q3 2024 · Nov 30, 2022 $11.85K
Cost Of Revenue Q3 2024 · Nov 30, 2022 $32.35K
Revenue Q3 2024 · Nov 30, 2023 $2.85K
Revenue Q3 2024 · Nov 30, 2023 $18.44K
Revenue Q3 2024 · Nov 30, 2022 $10.12K
Revenue Q3 2024 · Nov 30, 2022 $19.67K